Optimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability Testing
28. November 2023 07:42 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health...
Optimi Health Welcomes Dr. Preston A. Chase as New Chief Science Officer
07. November 2023 07:30 ET
|
Optimi Health Corp.
Optimi Health Introduces New Chief Science Officer Dr. Preston A. Chase.
Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market
17. Mai 2023 08:15 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, May 17, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...